10-Q: Healthcare Integrated Technologies Reports Increased Operating Expenses and Net Loss in Q1 2025
Quarterly Report
Healthcare Integrated Technologies experienced a significant increase in operating expenses and a net loss for the quarter ended October 31, 2024, despite raising substantial capital through equity sales.
Summary
- Healthcare Integrated Technologies reported a net loss of $684,138 for the three months ended October 31, 2024, compared to a net loss of $228,500 for the same period in 2023.
- Operating expenses increased significantly to $670,201, up from $215,656 in the prior year, driven by higher salaries, contract labor, professional fees, and stock-based compensation.
- The company raised $2,452,000 through the sale of common stock at an average price of $0.10 per share during the quarter.
- The company's working capital improved to a surplus of $1,322,461, compared to a deficit of $799,938 at the end of the previous fiscal year.
- The company continues to develop its healthcare technology solutions, including SafeSpace, SafeFace, and SafeGuard, but has not yet generated revenue.
- The company has a history of losses and an accumulated deficit, raising substantial doubt about its ability to continue as a going concern.
Sentiment
Score: 3
Explanation: The document reveals significant financial challenges, including a substantial net loss, increased operating expenses, and a going concern qualification. While the company has raised capital, the lack of revenue and defaults on debt obligations create a negative outlook.
Positives
- The company successfully raised $2,452,000 through equity sales, strengthening its cash position.
- Working capital improved significantly, moving from a deficit to a surplus.
- The company continues to develop and pilot test new healthcare technology products.
- The company has added key personnel to its management team and board of directors.
Negatives
- The company experienced a substantial increase in net loss compared to the same period last year.
- Operating expenses increased significantly, driven by higher personnel costs and professional fees.
- The company has not yet generated any revenue from its products.
- The company's auditors have raised concerns about its ability to continue as a going concern.
- The company has defaulted on certain promissory notes.
Risks
- The company's ability to continue as a going concern is dependent on securing additional funding and generating revenue.
- The company faces risks related to maintaining adequate capital, competition, and changes in regulations.
- The company has a history of losses and an accumulated deficit.
- The company has defaulted on certain debt obligations, including 5% convertible promissory notes and a note payable to Acorn Management Partners, LLC.
- The company's disclosure controls and procedures were deemed ineffective.
Future Outlook
The company intends to finance its future activities and working capital needs largely from the sale of private and/or public equity securities with additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. There is no guarantee that additional capital or debt financing will be available when and to the extent required, or that if available, it will be on terms acceptable to the company.
Management Comments
- Our mission is to grow a profitable healthcare technology company by focusing on our core product, continuing the development of our proprietary software, and developing new uses and product lines for our technology.
- Our management team is focused on maintaining financial flexibility and assembling the right complement of personnel and outside consultants required to successfully execute our mission.
Industry Context
The company operates in the healthcare technology sector, which is experiencing rapid growth and innovation. The company's focus on ambient fall detection, time and attendance reporting, and elopement detection aligns with the increasing demand for technology-driven solutions in continuing care and home care settings. However, the company faces competition from established players and other emerging companies in this space.
Comparison to Industry Standards
- The company's lack of revenue generation is a significant deviation from industry standards for companies at a similar stage of development.
- The substantial increase in operating expenses, particularly in stock-based compensation, is higher than what is typically seen in comparable early-stage technology companies.
- The company's reliance on equity financing and short-term loans from related parties is not uncommon for startups, but the level of dependence and the going concern qualification raise concerns.
- Compared to companies like Alarm.com or ADT in the home security space, Healthcare Integrated Technologies is still in the early stages of product development and market validation.
- Unlike established healthcare technology companies like Cerner or Allscripts, Healthcare Integrated Technologies is not yet generating revenue from its products and services.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Board of Directors | Micheal Coach Burt | 2024-08-23 | New appointment | |
| Fractional Chief Financial Officer | Timothy R. Brady | 2024-10-01 | New appointment | |
| Chief Customer Officer | Caleb Dixon | 2024-11-05 | New appointment | |
| Chief Financial Officer | Timothy Brady | 2024-12-01 | New appointment | |
| Chief Commercial Officer | Theo Davis | 2024-12-05 | New appointment |
Legal Proceedings
- Apex Funding Source, LLC filed a lawsuit against the company's subsidiaries and related parties for an alleged guarantee of a loan to Blue Earth Resources, Inc.
Related Party Transactions
- The company has relied on short-term loans from related parties, primarily shareholders.
- The company has a Non-Employee Chief Executive Officer Engagement Agreement with Platinum Equity Advisors, LLC, a related party.
- The company issued a Promissory Note to Platinum Equity Advisors, LLC.
- The company has a sublease agreement with Blue Earth Resources, Inc., an entity related to the company through common management control.
Stakeholder Impact
- Shareholders face the risk of further dilution due to the company's reliance on equity financing.
- Employees may be impacted by the company's financial instability and potential restructuring.
- Customers may be concerned about the company's ability to deliver on its product promises.
- Creditors face the risk of non-payment due to the company's defaults on debt obligations.
- Suppliers may be impacted by the company's financial instability and potential payment delays.
Next Steps
- The company intends to continue developing and refining its products.
- The company plans to seek additional funding through equity sales and other financing sources.
- The company is negotiating amendments to defaulted promissory notes.
- The company will focus on generating revenue from its products.
Key Dates
| Date | Description |
|---|---|
| 2018-03-01 | Issuance of 5% Convertible Promissory Notes began. |
| 2020-08-11 | Agreement to repurchase shares from Acorn Management Partners, LLC and issuance of a promissory note. |
| 2023-08-01 | Effective date of the Non-Employee Chief Executive Officer Engagement Agreement, and employment agreements for the Chief Technology Officer and Chief Medical Officer. |
| 2023-09-18 | Apex Funding Source, LLC filed a lawsuit against the company's subsidiaries and related parties. |
| 2024-01-31 | Formalization of employment agreements for the CEO, CTO, and CMO. |
| 2024-04-18 | Lender filed a motion seeking partial summary judgment in the lawsuit. |
| 2024-06-12 | Issuance of a Promissory Note to Platinum Equity Advisors, LLC. |
| 2024-06-15 | Non-Employee Chief Strategy Officer Engagement Agreement with Dustin M. Hillis. |
| 2024-07-31 | End of the company's fiscal year. |
| 2024-08-25 | Issuance of shares to a board member as compensation. |
| 2024-09-01 | Issuance of shares to a consultant. |
| 2024-09-20 | Completion of a private placement of shares. |
| 2024-09-26 | Completion of a private placement of shares. |
| 2024-10-01 | Appointment of Timothy R. Brady as Fractional Chief Financial Officer. |
| 2024-10-08 | Completion of multiple private placements of shares. |
| 2024-10-10 | Completion of multiple private placements of shares. |
| 2024-10-18 | Completion of a private placement of shares. |
| 2024-10-19 | Issuance of shares to consultants. |
| 2024-10-22 | Completion of multiple private placements of shares. |
| 2024-10-24 | Completion of multiple private placements of shares. |
| 2024-10-25 | Completion of multiple private placements of shares and issuance of shares for settlement of accounts payables. |
| 2024-10-29 | Completion of a private placement of shares and issuance of shares to the Chief Strategy Officer. |
| 2024-10-31 | End of the reporting period and completion of a private placement of shares. |
| 2024-11-01 | Issuance of unregistered common stock. |
| 2024-11-05 | Issuance of unregistered common stock and appointment of Caleb Dixon as Chief Customer Officer. |
| 2024-11-06 | Issuance of unregistered common stock. |
| 2024-11-11 | Issuance of unregistered common stock. |
| 2024-12-01 | Contractor agreement with Timothy Brady as Chief Financial Officer. |
| 2024-12-05 | Contractor agreement with Theo Davis as Chief Commercial Officer. |
| 2024-12-09 | Announcement of the appointment of Theo Davis. |
| 2024-12-12 | Due date for the Promissory Note to Platinum Equity Advisors, LLC. |
| 2024-12-13 | Date of the quarterly report. |
Keywords
healthcare technology, financial results, operating expenses, net loss, equity financing, going concern, stock-based compensation, intangible assets, promissory notes, defaults
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.